CD8A and neoplasm: As expected, anti–PD-L1 therapy had little effect on tumor growth in control cells or LCOR-OE cells, but we observed strong tumor suppression in LSKAA-OE tumors (Figure 6D), along with increasing immune cell infiltration, especially of CD8+ T cells (Figure 6E).